The provided text contains only web shop instructions and lacks any clinical data regarding the prognostic value of NPAR/UAR in MINOCA patients.
Do elevated NPAR and UAR levels predict poor short-term outcomes in MINOCA patients?
Elevated NPAR and UAR levels may serve as novel biomarkers for risk stratification in MINOCA patients.
Elevated NPAR and UAR levels jointly predict poor short-term outcomes in MINOCA patients, and their synergistic effect is independent of CSFP status. These findings suggest a novel biomarker-based strategy for risk stratification and targeted intervention in microvascular myocardial infarction.
Li et al. (Thu,) conducted a other in MINOCA with Coronary Slow Flow Phenomenon. NPAR/UAR was evaluated. The provided text contains only web shop instructions and lacks any clinical data regarding the prognostic value of NPAR/UAR in MINOCA patients.